Pharmaceutical

The year 2024 has kicked off on a positive note with the first earnings season showing promising results across various...

US Intelligence Unveils Ongoing Chinese Cyber Campaign In recent years, cyber warfare has become an increasingly prevalent threat to national...

A Look into Irish Innovation: 10 Promising Startups to Keep an Eye on in 2024 and Beyond Ireland has long...

Monomer Bio, a leading provider of innovative laboratory automation solutions for drug discovery, has recently announced securing $5.6 million in...

Court Receives $105 Million in Funding for Innovative Autoimmune Disease Reprogramming with Pharmaceutical Assistance In a groundbreaking development, the Court...

Boston has long been recognized as a global leader in the biotech industry, with its renowned universities, research institutions, and...

Exploring Alternatives in an Uncertain Market: Beyond Survival Mode In today’s rapidly changing and uncertain market, businesses are facing unprecedented...

The Ability of AI to Create Novel Proteins Calls for a Discussion on Biosecurity Artificial Intelligence (AI) has made significant...

EMA’s CHMP Declines Renewal of Translarna and Rejects Nezglyal and Syfovre as New Medicines The European Medicines Agency’s (EMA) Committee...

Nanoform, a leading nanoparticle medicine enabling company, has recently reported promising clinical results for patient-centric nanotechnology-enhanced enzalutamide. Enzalutamide is a...

Micah Lieberman, the founder of ClinEco and CHI, recently shared his insights at the SCOPE (Summit for Clinical Ops Executives)...

Understanding IDMP: How Standardizing Global Medicinal Product Documentation Improves Patient Safety and Regulatory Efficiency in the Pharmaceutical Industry In the...

2024 Trends: A Comprehensive Look at the Twists and Turns in Biopharma Dealmaking The biopharmaceutical industry is constantly evolving, driven...

Organ-on-a-Chip Companies Revolutionize Drug Trials, Going Beyond Animal Testing In the world of pharmaceutical research and development, finding safe and...

Former Bayer R&D Chief Assumes CEO Role at BenevolentAI In a significant move for the pharmaceutical industry, Dr. Joerg Moeller,...